Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. GSK PHARMA GENNEX LAB./
GSK PHARMA
 
P/E (TTM) x 35.6 62.1 57.3% View Chart
P/BV x 4.6 18.8 24.3% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 GENNEX LAB.   GSK PHARMA
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
GSK PHARMA
Mar-23
GENNEX LAB./
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs91,684 0.5%   
Low Rs51,231 0.4%   
Sales per share (Unadj.) Rs3.4191.9 1.8%  
Earnings per share (Unadj.) Rs0.335.9 0.8%  
Cash flow per share (Unadj.) Rs0.339.8 0.8%  
Dividends per share (Unadj.) Rs032.00 0.0%  
Avg Dividend yield %02.2 0.0%  
Book value per share (Unadj.) Rs4.5102.9 4.4%  
Shares outstanding (eoy) m176.64169.41 104.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.17.6 27.3%   
Avg P/E ratio x25.040.6 61.5%  
P/CF ratio (eoy) x21.036.7 57.4%  
Price / Book Value ratio x1.514.2 10.8%  
Dividend payout %089.2 0.0%   
Avg Mkt Cap Rs m1,229246,858 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m795,950 1.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m59332,517 1.8%  
Other income Rs m401,007 3.9%   
Total revenues Rs m63333,524 1.9%   
Gross profit Rs m478,033 0.6%  
Depreciation Rs m9658 1.4%   
Interest Rs m1418 74.7%   
Profit before tax Rs m648,364 0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m152,288 0.6%   
Profit after tax Rs m496,076 0.8%  
Gross profit margin %7.924.7 32.0%  
Effective tax rate %22.827.4 83.3%   
Net profit margin %8.318.7 44.4%  
BALANCE SHEET DATA
Current assets Rs m48724,943 2.0%   
Current liabilities Rs m29513,264 2.2%   
Net working cap to sales %32.335.9 89.9%  
Current ratio x1.61.9 87.7%  
Inventory Days Days497 4.2%  
Debtors Days Days57,912,589216 26,819,150.8%  
Net fixed assets Rs m8356,988 11.9%   
Share capital Rs m1801,694 10.6%   
"Free" reserves Rs m62315,735 4.0%   
Net worth Rs m80417,430 4.6%   
Long term debt Rs m1630-   
Total assets Rs m1,32231,930 4.1%  
Interest coverage x5.7462.6 1.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.41.0 44.1%   
Return on assets %4.719.1 24.9%  
Return on equity %6.134.9 17.6%  
Return on capital %8.048.1 16.6%  
Exports to sales %42.10-   
Imports to sales %13.648.1 28.3%   
Exports (fob) Rs m250NA-   
Imports (cif) Rs m8115,630 0.5%   
Fx inflow Rs m2501,622 15.4%   
Fx outflow Rs m8615,630 0.6%   
Net fx Rs m164-14,008 -1.2%   
CASH FLOW
From Operations Rs m2374,842 4.9%  
From Investments Rs m-3838,079 -4.7%  
From Financial Activity Rs m210-15,433 -1.4%  
Net Cashflow Rs m64-2,512 -2.5%  

Share Holding

Indian Promoters % 23.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 11.6 -  
FIIs % 0.0 2.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 25.0 305.6%  
Shareholders   69,723 114,663 60.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs GSK Pharma Share Price Performance

Period GENNEX LABORATORIES GSK Pharma S&P BSE HEALTHCARE
1-Day 3.27% 3.05% 1.18%
1-Month -12.26% -9.96% -0.75%
1-Year 195.41% 52.31% 61.82%
3-Year CAGR 63.80% 10.81% 18.16%
5-Year CAGR 40.61% 8.40% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.